# Effect of Bile Acids on GLP-1 Secretion

> **NCT01666223** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Type 2 Diabetes
- Obesity

## Interventions

- **DRUG:** Colesevelam
- **DRUG:** Chenodeoxycholic Acid
- **OTHER:** saline
- **DRUG:** Colesevelam 3750 mg + chenodeoxycholic acid 1250 mg

## Key facts

- **NCT ID:** NCT01666223
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666223, "Effect of Bile Acids on GLP-1 Secretion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01666223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*